Erythema multiforme and toxic epidermal necrolysis: A comparative study

American Journal of Dermatopathology

Volumn 19, Issue 2, 1997, Pages 127-132

  Paquet, P ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Erythema multiforme; Lyell's syndrome; Toxic epidermal necrolysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; ERYTHEMA MULTIFORME; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CELL COUNT; DENDRITIC CELLS; EPIDERMAL NECROLYSIS, TOXIC; EPIDERMIS; ERYTHEMA MULTIFORME; FEMALE; GRANULOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; SKIN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0343036291     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199704000-00005     Document Type: Article

References (14)

1. 1, 2 and 3: study of 60 cases. J Am Acad Dermatol 1985;13:623-5.
2. Patterson R, Dykewicz M, Gonzalzles A, et at. Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy. Chest 1990;98:331-6.
3. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrotysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993;129:92-6.
4. Piérard GE, Franchimont C, Abrassart C, et al. Les dermatoses bulleuses. Rev Med Liège 1986;41:591-601.
5. Parker S, Black M. Subepidermal bullous disorders. In: Farmer ER, Hood AF eds. Pathology of the Skin. Norwalk: Appleton and Lange, 1990;141-59.
6. Coté B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau JC, Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol 1995;131:1268-72.
7. Huff JC, Weston W, Tonnesen M. Erythema multiforme: a critical review of characteristics, diagnostic criteria and causes. J Am Acad Dermatol 1983;8:763-75.
8. Stern R, Chan HL. Usefulness of report literature in determining drugs responsible for toxic epidermal necrolysis. J Am Acad Dermatol 1989;21:317-22.
9. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE. Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis. Arch Dermatol 1994;130:605-8.
10. Villada G, Roujeau JC, Clerici T, Bourgault I, Revuz J. Immunopathology of toxic epidermal necrolysis. Arch Dermatol 1992;128:50-3.
11. Heng MCY, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol 1991;25:778-86.
12. Howland W, Golitz L, Weston W, Huff JC, Erythema multiforme: clinical, histopathologic and immunologic study. J Am Acad Dermatol 1984;10:438-46.
13. Zaim MT, Giorno RC, Golitz LE, Kunke KS, Huff JC. An immunopathological study of herpes associated erythema multiforme. J Cutan Pathol 1987;14:257-62.
14. Sueki H, Whitaker D, Buchsbaum M, Murphy GF. Novel interactions between dermal dendrocytes and mast cells in human skin: implications for hemostasis and matrix repair. Lab Invest 1993;69:160-72.